Beroni Group Ltd

Overview

Compare with another stock.

• TickerBNIGF on OTC¹
• IndustryPharmaceutical Preparations¹
• HeadquartersC3¹
• Incorporated inAustralia²
• Business addressSuite 401, 447 Kent Street, Sydney, C3 Nsw 2000²

See how the biggest companies compare on our leaderboards

Filings

14 filings to the SEC since October 2021: 14 other. The latest 14:

1. Jun 13, 2025SEC STAFF ACTION EDGAR
2. Feb 14, 2024F-1/A EDGAR
3. Jan 24, 2024F-1/A EDGAR
4. Dec 14, 2023F-1/A EDGAR
5. Nov 7, 2023F-1/A EDGAR
6. Aug 21, 2023F-1/A EDGAR
7. Feb 2, 2023F-1/A EDGAR
8. Dec 23, 2022F-1/A EDGAR
9. Jun 9, 2022F-1/A EDGAR
10. May 24, 2022F-1/A EDGAR
11. Apr 14, 2022F-1/A EDGAR
12. Feb 4, 2022F-1/A EDGAR
13. Jan 24, 2022F-1/A EDGAR
14. Dec 20, 2021F-1 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

SEC filer profile

How Beroni Group Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARBeroni Group Ltd¹
• CIK0001851651
• Incorporated inAustralia¹
• Fiscal year endsDecember 31¹
• Industry code (SIC)2834 Pharmaceutical Preparations¹
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
• Business addressSuite 401, 447 Kent Street, Sydney, C3 NSW 2000¹
• Phone61 2 80513055¹
• On EDGAR sinceDec 20, 2021¹
• Filings14 in all: F-1/A (12), F-1 (1), SEC STAFF ACTION (1)¹